Tag archive for ‘Mylan N.V.’
(L-R) Robert J Coury, Mylan and Joseph Papa, Perrigo
Niva Goldberg On Wednesday, November 4th, 2015

Mylan receives US FTC Clearance to buy Perrigo

Under the settlement agreement with the Federal Trade Commission, subject to final approval, Mylan NV has agreed to sell the rights and assets related to seven generic drugs to secure regulatory approval More...

(L-R) Robert J Coury, Mylan and Joseph Papa, Perrigo
News Brief On Tuesday, November 3rd, 2015

Why Mylan is taking its Perrigo pursuit to Tel Aviv’s stock exchange

Shares in the U.S. generic drugmaker Mylan will begin trading on the Tel Aviv Stock Exchange Wednesday, the TASE said Monday. The move comes after Mylan last week won an Israeli court ruling rejecting Perrigo’s More...

(L-R) Robert J Coury, Mylan and Joseph Papa, Perrigo
Niva Goldberg On Tuesday, September 15th, 2015

Mylan Begins $27 billion Hostile Bid for Perrigo

  Mylan N.V. on Monday announced that it has officially took its $27 billion takeover bid directly to shareholders of Perrigo Company plc (NYSE: PRGO; TASE). In April 29th Mylan made the same offer,  More...

Shiri Habib-Valdhorn On Thursday, August 13th, 2015

Mylan might make do with only 50% of Perrigo

  Generic pharmaceutical company Mylan N.V. (MYL) today officially announced a reduction in the approval requirement for the Perrigo Company (NYSE:PRGO; TASE:PRGO) deal from 80% to 50%. This means that More...

Shiri Habib-Valdhorn On Monday, July 27th, 2015

Three Way Takeover Battle – The End: Teva losing $300 million on Mylan stake

  Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has officially announced that it is withdrawing its bid to buy generic pharmaceuticals rival Mylan N.V. after agreeing to buy Allergan Generics More...

Niva Goldberg On Thursday, July 23rd, 2015

Three ways takeover battle: Mylan invokes “poison pill” to block Teva hostile takeover

  Dutch Stichting Foundation notified Mylan that it has exercised its call option to acquire 488, 388, 431 Mylan preferred shares pursuant to the Call Option Agreement, dated April 3, 2015, between More...

Niva Goldberg On Thursday, July 16th, 2015

Mylan battles against Teva takeover: US consumer groups oppose merger

“A takeover of Mylan by Teva is a bad deal for consumers, ” claim. US consumer organizations that have jointly written to the Federal Trade Commission (FTC) demanding that it block the Teva-Mylan More...

Niva Goldberg On Tuesday, July 7th, 2015

Three Way Takeover Battle: Teva plans raising Mylan bid to $43 billion – report

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA), the Israeli drugmaker, is preparing to improved proposal for US rival Mylan to as much as $43 billion, $86 to $88 a share, as soon as this More...

Three Way Takeover Battle: Teva Completes the Purchase of 4.61 Percent Interest in Mylan N.V.

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has completed first step to buy its rival Mylan N.V. (Nasdaq: MYL). The Israeli giant announced on Friday that it has completed the purchase of a 4.61% More...

(L-R) Robert J Coury, Mylan and Joseph Papa, Perrigo
Shiri Habib-Valdhorn On Thursday, June 18th, 2015

Three Way Takeover Battle: Mylan to list on TASE if Perrigo bid succeeds

  One of the main worries of Tel Aviv Stock Exchange (TASE) leaders recently has been the expected delisting of Perrigo Company (NYSE:PRGO; TASE:PRGO), if and when the company’s acquisition by Mylan More...

Wordpress site Developed by Fixing WordPress Problems